Our Team
Dr. Klaus Weber
PhD, DVM, M.Sc. Biol., Toxicologic Pathologist, Diplomate JSTP
Klaus is the founder of the AnaPath Group and currently function as Director of the Board, CFO and senior pathologist, with more than 30 years professional experience, he started his career as DVM and later MS (biologist) at AWD Germed in East Germany, trained in human pathology in 1989/1990, before leaving in 1991 to join RCC Ltd Switzerland as a toxicologic pathologist. From 1992 onwards was Head of Pathology at RCC Ltd/Global Director Pathology Harlan Laboratories Ltd and from 1997 onwards as CSO of Harlan Inc. He started AnaPath GmbH in 2005 and AnaPath Services GmbH in 2013.
He is experienced in all laboratory species, includin birds, fish and invertebrates, from short-term, long-term and oncogenicity studies with specialties in neuropathology, inhalation pathology, sperm and ovary staging and bone marrow evaluation.
Ing. BioMed. Nils Warfving
Nils is the CEO of AnaPath Services, bringing over a decade of experience and leadership within the company. Prior to his current role, he held several key positions, including Head of Special Technologies and Medical Device Studies, Senior Business Developer, and Scientific Advisor. Earlier in his career, he also served as Study Director / Principal Investigator and Head of IT. With a background in engineering but a lifelong passion for life sciences, Nils offers a unique perspective in addressing complex challenges beyond the scope of routine histology services. As CEO, he is driving AnaPath Services and the AnaPath Group`s strategic vision forward, fostering innovation, strengthening global partnerships, positioning the company at the forefront of advanced laboratory technologies and the science of histopathology, while strengthen the position of the AnaPath Group as a comprehensive CRO for toxicology at AnaPath Research (Barcelona).
Dr. Robert Kreutzer
DVM, PhD, FTA Pathology
Pathologist with more than 20 years professional experience in academia and pharmaceutic industry. After graduation form the Faculty of Veterinary Medicine Bucharest Romania he started his career at the Institute for Diagnosis Animal Health in Bucharest Romania as DVM (Veterinary Specialist in Laboratory Diagnosis) and then worked as research scientist / molecular and veterinary pathologist at the Institute for Veterinary-Pathology, Justus-Liebig University Giessen Germany, at the Department of Pathology University of Veterinary Medicine, Hannover Germany and further as molecular and discovery pathologist at Novartis Pharma AG, Basel, Switzerland. He is holding a Dr. med. vet. title in Molecular Veterinary Medicine awarded with summa cum laude by the Justus Liebig University Giessen, Germany and the Graduate College “Veterinary Molecular Medicine” Giessen Germany and a PhD title in Pathology (molecular neuropathology) awarded by the University of Veterinary Medicine, Hannover Germany and the Center for Systems Neuroscience Hannover Germany. Robert Kreutzer is experienced in molecular and discovery pathology (i.e. evaluation of animal models), Neuroscience, Oncology and in advanced microscopy approaches (i.e. TEM, multispectral and confocal microscopy).
Dr. Yoshimasa Okazaki
DVM, PhD, Toxicologic Pathologist, Diplomate JSTP, Diplomate JCVP
Yoshimasa started his career as toxicologic pathologist in 1989 at the pharmaceutical company in Japan, Dainippon Pharmaceutical Co. Ltd., after graduating from the Faculty of Veterinary Sciences of Miyazaki University, Japan. From 1994 onwards, he gained experience in the field of toxicology and toxicologic pathology at “Astellas Pharma Inc.” and at the non-clinical Contract Research Organizations “Mitsubishi Chemical Safety Institute Ltd.”, “Harlan Laboratories Ltd.”, and the “Institute of Environmental Toxicology (IET)”.
Yoshimasa Okazaki returned to AnaPath GmbH in 2019 as toxicologic pathologist with more than 25 years of experience in rodents and non-rodents in short-term, long-term and oncogenicity studies. His specialty is in cardiovascular pathology and neurotoxicology.
Susanne Paepke
In 2002, she started her career as a laboratory technician in the pathology department of Harlan Laboratories Ltd. From 2013 onwards she moved to AnaPath GmbH in the same position and took over the responsibility of the principal investigator for histology and the organization of the laboratory, one year later. After this many years of experience in the GLP environment and the organization of the histology laboratory, Susanne moved to the position of Test Facility Manager in October 2016.
Abdallah Ben Abdeljelil Dipl. Biol.
Ben Abdeljelil has university degrees in Biology and Biotechnology. He has more than 20 years of experience in pre-clinical CROs (e.g., Harlan Laboratories) where he held positions as study director, team leader, and fetal pathologist. He has deep experience in the areas of reproductive toxicology, cytotoxicity, genotoxicity, and molecular target localization and characterization. At AnaPath, in his role as principal investigator / study director, Ben Abdeljelil provides scientific support to client’s projects. Ben Abdeljelil is our fetal pathologist and leads the immunohistochemistry/TCR laboratory.
Dr. Roman Schönauer
He is a cell biologist with a doctoral degree from ETH Zürich and more than 15 years of experience in biomedical research. After his PhD in the field of muscle proteins, he moved on as a postdoctoral fellow to University Hospital Zürich (Cardiovascular Surgery Research), where he focused on cellular/molecular alterations in cardiomyopathies as well as on cardiovascular tissue engineering. Starting in 2011, he was a senior postdoctoral fellow at the Institute of Anatomy, University of Bern, where he analyzed the role of several factors on membrane repair in human cells. He has broad experience in cell and molecular biological research, immunohistochemistry, advanced microscopical techniques, and image analysis. As principal investigator for studies in the field of immunohistochemistry and special technologies, he provides valuable scientific support to our clients. He joined AnaPath in 2018.
Dr. Aléthéa Liens
Aléthéa has a master’s degree in Materials Science and Engineering with a PhD in dental implantology materials from The National Institute of Applied Sciences (INSA) of Lyon, France. Her PhD was realized in close collaboration with a dental implant company for which she worked closely for five years. Her research mainly focused on the development and characterization of innovative materials for dental applications. After finishing her PhD, Aléthéa worked as a pre-clinical and translational research scientist in one of the leading dental implant companies on the market. Aléthéa has strong and extensive expertise in metallurgy, mainly in biomedical grade titanium alloys and metallic glasses; advanced ceramics including zirconia; mechanical testing; dental implantology; dentistry; osseointegration of bone; pre-clinical evaluation; and characterization techniques, such as TEM, SEM, EDX, XRD or EBSD. Aléthéa works as a principal investigator and project manager in the Special Technologies and Medical Devices Department at AnaPath since August 2020 supporting, implementing, and conducting complex investigations.
Dr. Olivia Richard DVM, Veterinary Pathologist, Diplomate ECVP
Olivia studied veterinary medicine at the University of Bern in Switzerland. After her studies, she earned her doctoral degree in the field of vaccine testing and optimization at the Institute of Animal Pathology (ITPA), Vetsuisse Faculty at the University of Bern. Based on her work, the recommended vaccination schema against Clostridium perfringens type C was optimized.
Olivia completed the residency program of the European College of Veterinary Pathology (ECVP) at the ITPA under the guidance of Prof. Horst Posthaus and Prof. Sven Rottenberg. In the residency program, Olivia focused on diagnostic necropsies and biopsies of companion animals, farm animals and wildlife.
Olivia joined AnaPath as a toxicologic pathologist in 2021.
Dr. Pranitha Kamat Ebert
Pranitha holds a PhD in biomedical research from the University of Bern and has conducted extensive research on vascular pathology, largely in the context of myocardial infarction and transplantation. She has experience in developing and implementing protocols for several molecular pathology techniques. At AnaPath, Pranitha is part of the immunohistochemistry team as principal investigator. With an active interest in science communication, Pranitha also supports communication and marketing for AnaPath.
ABOUT ANAPATH
AnaPath Services Is a Swiss-based contract laboratory specializing in histopathology services. Based in the heart of Europe, close to the pharmaceutical capital Basel, we are your first stop for any toxicological or molecular pathology needs.